tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Genmab: Near-Term Guidance Miss Offset by Strong Results and Blockbuster Late-Stage Pipeline Upside
PremiumRatingsGenmab: Near-Term Guidance Miss Offset by Strong Results and Blockbuster Late-Stage Pipeline Upside
1d ago
Genmab Launches DKK 725 Million Share Buy-Back to Cover RSU Commitments
Premium
Company Announcements
Genmab Launches DKK 725 Million Share Buy-Back to Cover RSU Commitments
1d ago
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
Premium
The Fly
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
1d ago
Genmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
PremiumCompany AnnouncementsGenmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
15d ago
GMAB Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
GMAB Upcoming Earnings Report: What to Expect?
16d ago
Genmab Grants New RSUs and Warrants to Employees to Strengthen Long-Term Incentives
Premium
Company Announcements
Genmab Grants New RSUs and Warrants to Employees to Strengthen Long-Term Incentives
20d ago
Genmab: Diversified Oncology Pipeline Supports Upside and Maintained Buy Rating Despite EPKINLY Phase 3 Setback
PremiumRatingsGenmab: Diversified Oncology Pipeline Supports Upside and Maintained Buy Rating Despite EPKINLY Phase 3 Setback
30d ago
Genmab price target lowered to $39 from $41 at H.C. Wainwright
Premium
The Fly
Genmab price target lowered to $39 from $41 at H.C. Wainwright
30d ago
Genmab price target raised to $38.50 from $34.70 at BofA
Premium
The Fly
Genmab price target raised to $38.50 from $34.70 at BofA
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100